9 completed, 4 unknown, 1 not yet recruiting, 1 recruiting. 15 Phase 2, 4 Phase 3, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 15 | Completed 9, Unknown 4, Not yet recruiting 1, Recruiting 1 |
| Phase 3 | 4 | Completed 3, Not yet recruiting 1 |
| Phase 1 | 3 | Completed 3 |
Follow Long-Term Synaptic Depression: new trials by email Literature Review of Long-Term Synaptic Depression trials Research Report on Long-Term Synaptic Depression
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bovis Calculus Stativus Treat Acute Cerebral Ischemic Stroke With Impaired Consciousness Bovis Calculus Stativus (BCS), Placebo - Acute Ischemic Stroke AIS, Impaired Consciousness | Phase 2 / Phase 3 | Not yet recruiting | Xiang Luo | 220 | 2025-12-15 | 2025-12-18 |
| Tirofiban After Successful MT Recanalization in AIS Tirofiban, Saline placebo - Acute Ischemic Stroke, Vessel Occlusion | Phase 2 / Phase 3 | Completed | Xiang Luo | 1380 | 2024-04-09 | 2026-03-11 |
| Research of SORD-CMT Natural History and Epalrestat Treatment Epalrestat - Charcot-Marie-Tooth Disease (CMT) | Phase 2 | Unknown | The Third Xiangya Hospital of Central South University | 30 | 2023-04-01 | 2023-04-18 |
| Carrelizumab Combined With Chemotherapy for Adjuvant Therapy of Esophageal Squamous Cell Carcinoma Camrelizumab, Paclitaxel, Cisplatin - Esophagus Cancer | Phase 2 | Unknown | Tianjin Medical University Cancer Institute and Hospital | 23 | 2020-11-26 | 2022-12-05 |
| Effectiveness of Recombinant Human Growth Hormone Therapy for Children With PMS recombinant human growth hormone, Saline - Phelan-McDermid Syndrome, Growth Hormone Treatment | Phase 1 / Phase 2 | Completed | Affiliated Hospital of Jiangnan University | 6 | 2020-06-14 | 2022-10-10 |
| Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA gemcitabine and oxaliplatin., Afatinib - Gallbladder Carcinoma | Phase 2 | Recruiting | Shanghai Jiao Tong University School of Medicine | 102 | 2020-06-01 | 2024-10-16 |
| Efficacy and Safety of Lidocaine Infusion Treatment in Management of Neuropathic Pain Lidocaine HCl, Normal saline - Postherpetic Neuralgia, Diabetic Polyneuropathy | Phase 2 | Unknown | Seoul National University Hospital | 44 | 2015-08-01 | 2015-11-05 |
| No Treatment Versus Oral Ibuprofen Treatment for Patent Ductus Arteriosus in Preterm Infants Oral ibuprofen, Normal saline - Bronchopulmonary Dysplasia (BPD) | Phase 2 | Completed | Samsung Medical Center | 142 | 2014-07-01 | 2020-01-13 |
| Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) in Patients With Advanced Gastric Cancer S-1, leucovorin, oxaliplatin - Gastric Cancer | Phase 2 | Unknown | Jilin Provincial Tumor Hospital | 49 | 2013-11-01 | 2015-03-05 |
| Efficiency of Placental Drug MelsmonĀ® in Correction of Climacteric Symptoms in Premenopausal Women Melsmon, Placebo - Climacteric Syndrome | Phase 2 / Phase 3 | Completed | Inna I. Kovalenko | 40 | 2013-10-01 | 2016-04-25 |
| Use of a Novel Fibrin Sealant in Total Knee Arthroplasty Evicel Fibrin Spray - Osteoarthritis, Intraoperative Bleeding | Phase 2 / Phase 3 | Completed | Rush University Medical Center | 73 | 2012-05-01 | 2016-02-09 |
| Dl-3-n-butylphthalide and Cerebrolysin Treatment in Acute Ischemic Stroke Dl-3-n-butylphthalide, Cerebrolysin, Placebo - Acute Cerebral Stroke Within 12 Hours for the First Time | Phase 1 / Phase 2 | Completed | Shanghai 6th People's Hospital | 84 | 2010-01-01 | 2020-08-24 |
| Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in China S-1, leucovorin, oxaliplatin - Colorectal Cancer | Phase 1 / Phase 2 | Completed | Shen Lin | 20 | 2009-09-01 | 2015-05-19 |
| Efficacy of Udenafil After Radical Resection for Sigmoid Colon and Rectal Cancer Udenafil - Erectile Dysfunction, Sigmoid Colon Cancer | Phase 2 | Completed | Seoul National University Hospital | 46 | 2009-03-01 | 2012-09-05 |
| Efficacy and Safety Study of Magnesium Isoglycyrrhizinate Injection in Subjects With Acute Drug-induced Liver Injury Magnesium Isoglycyrrhizinate Injection 100mg OD, Magnesium Isoglycyrrhizinate Injection 200mg OD, Tiopronin Injection - Drug-Induced Liver Injury | Phase 2 | Completed | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 174 | 2007-12-01 | 2016-09-27 |
Ischemic Stroke (3) · Blood Loss, Surgical (1) · Bronchopulmonary Dysplasia (1) · Charcot-Marie-Tooth Disease (1) · Chemical and Drug Induced Liver Injury (1) · Colorectal Neoplasms (1) · Diabetic Neuropathies (1) · Ductus Arteriosus, Patent (1) · Erectile Dysfunction (1) · Esophageal Neoplasms (1) · Gallbladder Neoplasms (1) · Hemorrhage (1) · Neuralgia, Postherpetic (1) · Osteoarthritis (1) · Peripheral Nervous System Diseases (1)
Seoul National University Hospital (2) · Xiang Luo (2) · Affiliated Hospital of Jiangnan University (1) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) · Inna I. Kovalenko (1) · Jilin Provincial Tumor Hospital (1) · Rush University Medical Center (1) · Samsung Medical Center (1) · Shanghai 6th People's Hospital (1) · Shanghai Jiao Tong University School of Medicine (1) · Shen Lin (1) · The Third Xiangya Hospital of Central South University (1) · Tianjin Medical University Cancer Institute and Hospital (1)
China (8) · South Korea (3) · Russia (1) · United States (1)
Brett R Levine, MD (1) · Larisa V. Suturina, M.D. (1) · Lixia Xue, M.D., Ph.D. (1) · Minde Zeng, MD (1) · Peng Tang, archiater (1) · Se In Sung, M.D. (1) · Sung-Bum Kang, M.D., Ph.D (1) · Xiang Luo (1) · Xiang Luo, PhD MD (1) · Yingbin Liu, PHD (1) · Yong Chul Kim, PhD (1) · YueYing Liu, Phd (1)
PMID 10565650, PMID 11679600, PMID 26158159, PMID 27168844, PMID 29381569, PMID 32539121, PMID 36854604, PMID 41991238, PMID 42341797